世界中医药
文章摘要
引用本文:曾荣繁.清热祛痰汤治疗老年慢性阻塞性肺疾病的临床研究[J].世界中医药,2013,8(07):.  
清热祛痰汤治疗老年慢性阻塞性肺疾病的临床研究
Clinical Study on Qingrequtan Decoction in Treating Chronic Obstructive Pulmonary Disease Among Aged Patients
投稿时间:2013-03-03  
DOI:10.3969/j.issn.1673-7202.2013.06.008
中文关键词:  清热祛痰汤  老年慢性阻塞性肺疾病  急性加重期
English Keywords:Qingrequtan decoction  Aged people  Chronic obstructive pulmonary disease  Acute exacerbation  Efficacy
基金项目:
作者单位
曾荣繁 重庆市忠县中医院内科忠县404300 
摘要点击次数: 1266
全文下载次数: 1303
中文摘要:
      目的:观察清热祛痰汤治疗老年慢性阻塞性肺疾病急性加重期(AECOPD)的临床疗效。方法:选取我院呼吸科住院AECOPD患者120例采用随机数字表法随机分为观察组与对照组各60例,2组患者均给予常规治疗包括抗生素、支气管舒张剂、吸氧、对症治疗等,观察组加用自拟清热祛痰汤加减治疗,每日1剂,分早晚两次服用。2组患者以连续治疗14 d为1个疗程,比较临床疗效。结果:治疗1个疗程后,观察组总有效率明显高于对照组(χ2=10.457,P<0.01),具有统计学意义。2组患者治疗前各项症状、体征积分、FEV1%、FEV1/FVC与呼吸困难指数比较差异无统计学意义(P>0.05),治疗后各项指标均较治疗前有明显改善(P<0.01),但观察组较对照组改善明显(P<0.01),具有统计学意义。结论:清热祛痰汤治疗老年慢性阻塞性肺疾病急性加重期(AECOPD)效果理想,可显著改善临床症状、体征及肺功能状态,值得推广应用。
English Summary:
      To observe the clinical efficacy of Qingrequtan decoction treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) among aged people. Methods: One hundred and twenty AECOPD patients admitted to Respiratory Department of our hospital were selected and randomly divided into observation group (n=60) and control group (n=60) using a random number table. Patients in both groups were given conventional treatment, including antibiotics, bronchodilators, oxygen, and other treatment in light of symptoms. Patients in observation group received extra treatment of modified Qingrequtan decoction, one dosage a day, divided into two parts for morning administration and evening administration. One treatment course consisted of 14 continuous days of treatment, and clinical efficacy were compared. Results: After a course of treatment, the total effective rate in observation group was significantly higher than that in the control group (χ2=10.457,P<0.01),with statistical significance. There were no significant differences between the two groups in terms of symptoms, sign score, FEV1% and FEV1/FVC and dyspnea index of the patients before the treatment (P>0.05). There were obvious improvement of the indexes after treatment in both groups, and the observation group showed better improvement compared with the control group (P<0.01). Conclusion: Qingrequtan decoction treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) among aged people shows satisfactory therapeutic effect in improving clinical symptoms, signs and pulmonary function, which is worth generalizing.
查看全文  查看/发表评论  下载PDF阅读器